Clene Nanomedicine

Recent Finacing

Series D

Recent Raise

$42.5M

Clene Nanomedicine develops a nanotechnology platform for orally administered neurotherapeutics (CNM‑Au8) in clinical trials and produces ionic zinc/silver antiviral formulations; based in Salt Lake City with R&D/manufacturing in Maryland.

Founded 2013

Utah, United States

51-100

Publicly Traded

clene.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Pharmaceutical

Financials

$42.5M

Total Raised

1

Funding round

Team

Upgrade to view the team

See the team members at Clene Nanomedicine.